EUVIMEDEUVIMED entdecken
Open Access

What Antiepileptics Have the Highest Risk of Parkinsonism? A Disproportionality Analysis in the World Health Organisation Pharmacovigilance Database

Jean-Louis Montastruc iD

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.70201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Jean-Louis Montastruc. Beteiligte Einrichtung: Emeritus Professor of Medical and Clinical Pharmacology, Toulouse, France. Hauptthemen laut MEDLINE: Anticonvulsants, Pharmacovigilance, Parkinsonian Disorders, Parkinson Disease, Secondary. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The present study was performed to investigate which antiepileptic drug (AED) has the highest risk of drug‐induced parkinsonism (DIP).

Objective

The aim was to evaluate associations between AEDs and DIP reports in the World Health Organization pharmacovigilance database, Vigibase.

Methods

Individual case safety reports (ICSRs) in patients ≥45 years registered between January 1, 2000 and June 31, 2024 with carbamazepine, lamotrigine, levetiracetam, or sodium valproate as “Parkinson‐like events” (PLE) were extracted. Disproportionality analyses were performed, with cases being PLE and non‐cases all other ICSRs. Results are shown as reporting odds ratios (ROR).

Results

Among 16,174,796 ICSRs, 3339 reported PLE with the four AEDs, mainly in females between 45 and 64 years. The highest ROR value was with valproate sodium (3.09 [2.01–3.29]), followed by lamotrigine (2.14 [2.01–2.28]), levetiracetam (1.43 [1.32–1.55]), and carbamazepine (1.09 [1.01–1.17]). DIP risk increased with the number of associated AEDs.

Conclusions

Among AEDs, valproate sodium is associated with the higher risk of PLE and carbamazepine with the lowest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsPharmacovigilanceParkinsonian DisordersParkinson Disease, SecondaryHumansFemaleWorld Health OrganizationMiddle AgedMaleDatabases, FactualAgedLamotrigineValproic AcidCarbamazepineLevetiracetam

Stichwörter der Autor:innen

antiepilepticscarbamazepinedrug‐induced parkinsonismlamotriginelevetiracetamvalproate sodium

Substanzen

AnticonvulsantsLamotrigineValproic AcidCarbamazepineLevetiracetam

Autor:innen und Institutionen

  • Emeritus Professor of Medical and Clinical Pharmacology, Toulouse, France.

ORCID-Profile: Jean-Louis Montastruc

Zitieren

APA

Montastruc, J. L. (2025). What Antiepileptics Have the Highest Risk of Parkinsonism? A Disproportionality Analysis in the World Health Organisation Pharmacovigilance Database. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70201

Vancouver

Montastruc JL. What Antiepileptics Have the Highest Risk of Parkinsonism? A Disproportionality Analysis in the World Health Organisation Pharmacovigilance Database. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70201

BibTeX
@article{Montastruc2025,
  author = {Montastruc, Jean-Louis},
  title = {What Antiepileptics Have the Highest Risk of Parkinsonism? A Disproportionality Analysis in the World Health Organisation Pharmacovigilance Database},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.70201}
}
Kostenlos starten →